These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2783324)

  • 1. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo.
    Lycke N; Bromander AK; Ekman L; Karlsson U; Holmgren J
    J Immunol; 1989 Jan; 142(1):20-7. PubMed ID: 2783324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.
    Bromander A; Holmgren J; Lycke N
    J Immunol; 1991 May; 146(9):2908-14. PubMed ID: 1901890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
    Lycke NY
    J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
    J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholera toxin promotes B cell isotype differentiation.
    Lycke N; Strober W
    J Immunol; 1989 Jun; 142(11):3781-7. PubMed ID: 2785565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation.
    Lycke N; Severinson E; Strober W
    J Immunol; 1990 Nov; 145(10):3316-24. PubMed ID: 1700007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
    Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
    J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation.
    Anastassiou ED; Yamada H; Francis ML; Mond JJ; Tsokos GC
    J Immunol; 1990 Oct; 145(8):2375-80. PubMed ID: 2120330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation.
    Francis ML; Okazaki I; Moss J; Kurosky A; Pecanha LM; Mond JJ
    J Immunol; 1995 May; 154(10):4956-64. PubMed ID: 7730606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin.
    Woogen SD; Ealding W; Elson CO
    J Immunol; 1987 Dec; 139(11):3764-70. PubMed ID: 2824614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
    Agren LC; Ekman L; Löwenadler B; Lycke NY
    J Immunol; 1997 Apr; 158(8):3936-46. PubMed ID: 9103464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
    Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
    J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic stroma-derived T-cell inhibitory factor (TSTIF). 2: TSTIF acts on the antigen-presenting cell to inhibit antigen-stimulated T-cell proliferation.
    Tai XG; Kita Y; Toyooka K; Hamaoka T; Fujiwara H
    Thymus; 1993 Jun; 21(4):247-58. PubMed ID: 8284807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.
    Yamamoto M; Kiyono H; Yamamoto S; Batanero E; Kweon MN; Otake S; Azuma M; Takeda Y; McGhee JR
    J Immunol; 1999 Jun; 162(12):7015-21. PubMed ID: 10358143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression.
    Cong Y; Weaver CT; Elson CO
    J Immunol; 1997 Dec; 159(11):5301-8. PubMed ID: 9548469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
    Kim PH; Eckmann L; Lee WJ; Han W; Kagnoff MF
    J Immunol; 1998 Feb; 160(3):1198-203. PubMed ID: 9570534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.
    Schnitzler AC; Burke JM; Wetzler LM
    Infect Immun; 2007 Jun; 75(6):3150-9. PubMed ID: 17353279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages, rather than T and B cells are principal immunostimulatory target cells of Lycium barbarum L. polysaccharide LBPF4-OL.
    Zhang XR; Zhou WX; Zhang YX; Qi CH; Yan H; Wang ZF; Wang B
    J Ethnopharmacol; 2011 Jul; 136(3):465-72. PubMed ID: 21549827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.